A run on the biobank: What have we learned about type 1 diabetes from the nPOD tissue repository?

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 4, 2015, Pages 290-295

  Kaddis, John S ^a   Pugliese, Alberto ^b   Atkinson, Mark A ^c  

^a Department of Information Sciences ^*  (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

atrophy; immunity; infiltration; pancreas; regeneration

Indexed keywords

COMPLEMENT; CYTOKINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BIOBANK; BLOOD; CELL FUNCTION; CELL MASS; CELL REGENERATION; CELLULAR PARAMETERS; DISEASE COURSE; DONOR; EXTRACELLULAR MATRIX; HEALTH CARE FACILITY; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; PANCREAS; PANCREAS DUCT; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REVIEW; T LYMPHOCYTE; VASCULARIZATION; IMMUNOLOGY; PATHOLOGY;

DIABETES MELLITUS, TYPE 1; HUMANS; PANCREAS; TISSUE BANKS;

EID: 84937797996     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000171     Document Type: Review

References (62)

1. Beck RW, Tamborlane WV, Bergenstal RM, et al. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2012; 97: 4383-4389
2. Skyler JS, Greenbaum CJ, Lachin JM, et al. Type 1 Diabetes TrialNet: an international collaborative clinical trials network. Ann N Y Acad Sci. 2008; 1150: 14-24
3. Rich SS, Akolkar B, Concannon P, et al. Overview of the type I diabetes genetics consortium. Genes Immun. 2009; 10: S1-S4
4. Group TS. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci. 2008; 1150: 1-13
5. Kaddis JS, Olack BJ, Sowinski J, et al. Human pancreatic islets and diabetes research. JAMA. 2009; 301: 1580-1587
6. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014; 383: 69-82
7. Herold KC, Vignali DAA, Cooke A, Bluestone JA. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol. 2013; 13: 243-256
8. Roep BO, Tree TIM. Immune modulation in humans: implications for type 1 diabetes mellitus. Nat Rev Endocrinol. 2014; 10: 229-242
9. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009; 360: 1646-1654
10. Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med. 2012; 2: a007690
11. Morgan NG, Leete P, Foulis AK, Richardson SJ. Islet inflammation in human type 1 diabetes mellitus. IUBMB Life. 2014; 66: 723-734
12. Int Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol. 2014; 36: 569-579
13. Campbell-Thompson M, Wasserfall C, Kaddis J, et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes/Metab Res Rev. 2012; 28: 608-617
14. Planas R, Pujol-Borrell R, Vives-Pi M. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery. Immunol Lett. 2010; 133: 55-61
15. Pugliese A, Yang M, Kusmarteva I, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes. 2014; 15: 1-9
16. Rodriguez-Calvo T, Ekwall O, Amirian N, et al. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes. 2014; 63: 3880-3890
17. Ye J, Vives-Pi M, Gillespie KM. Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells. PLoS One. 2014; 9: e86985
18. Rowe P, Wasserfall C, Croker B, et al. Increased complement activation in human type 1 diabetes pancreata. Diabetes Care. 2013; 36: 3815-3817
19. Arif S, Leete P, Nguyen V, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes. 2014; 63: 3835-3845
20. Chen J, Feigenbaum L, Awasthi P, et al. Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Ralpha. Proc Natl Acad Sci USA. 2013; 110: 13534-13539
21. Gardner JM, Metzger TC, McMahon EJ, et al. Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4() T cells. Immunity. 2013; 39: 560-572
22. Cheung SS, Ou D, Metzger DL, et al. B7-H4 expression in normal and diseased human islet beta cells. Pancreas. 2014; 43: 128-134
23. Bogdani M, Johnson PY, Potter-Perigo S, et al. Hyaluronan and hyaluronanbinding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes. 2014; 63: 2727-2743
24. Floyel T, Brorsson C, Nielsen LB, et al. CTSH regulates beta-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci USA. 2014; 111: 10305-10310
25. Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015; 64: 1682-1687
26. Grzesik WJ, Nadler JL, Machida Y, et al. Expression pattern of 12-lipoxygenases in human islets with type 1 diabetes and type 2 diabetes. J Clin Endocrinol Metab 2014
27. Zhao Z, Low YS, Armstrong NA, et al. Repurposing cAMP-modulating medications to promote beta-cell replication. Mol Endocrinol. 2014; 28: 1682-1697
28. Yip L, Taylor C, Whiting CC, Fathman CG. Diminished adenosine A1 receptor expression in pancreatic alpha-cells may contribute to the pathology of type 1 diabetes. Diabetes. 2013; 62: 4208-4219
29. Piran R, Lee SH, Li CR, et al. Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes. Cell Death Dis. 2014; 5: e1357
30. Kavishwar A, Moore A. Sphingomyelin patches on pancreatic beta-cells are indicative of insulin secretory capacity. J Histochem Cytochem. 2013; 61: 910-919
31. Campbell-Thompson M, Wasserfall C, Montgomery EL, et al. PAncreas organ weight in individuals with disease-Associated autoantibodies at risk for type 1 diabetes. JAMA. 2012; 308: 2337-2339
32. Gaglia JL, Guimaraes AR, Harisinghani M, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Investig. 2011; 121: 442-445
33. Williams AJK, Chau W, Callaway MP, Dayan CM. Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabetic Med. 2007; 24: 35-40
34. Williams AJK, Thrower SL, Sequeiros IM, et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab. 2012; 97: E2109-E2113
35. Fonseca V, Berger LA, Beckett AG, Dandona P. Size of pancreas in diabetes mellitus: a study based on ultrasound. Br Med J. 1985; 291: 1240-1241
36. Lö hr M, Klö ppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987; 30: 757-762
37. Altobelli E, Blasetti A, Verrotti A, et al. Size of pancreas in children and adolescents with type I (insulin-dependent) diabetes. J Clin Ultrasound. 1998; 26: 391-395
38. Goda K, Sasaki E, Nagata K, et al. Pancreatic volume in type 1 und type 2 diabetes mellitus. Acta Diabetol. 2001; 38: 145-149
39. Gilbeau JP, Poncelet V, Libon E, et al. The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients. Am J Roentgenol. 1992; 159: 527-531
40. Int Veld P, Marichal M. Microscopic anatomy of the human islet of langerhans. In: Islam MS, editor. The islets of Langerhans. Springer Netherlands: Berlin; 2010. pp. 1-19
41. Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia. 1984; 26: 456-461
42. Czako L, Hegyi P, Rakonczay Z Jr, et al. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009; 9: 351-359
43. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005; 54: 1-28
44. Philippe MF, Benabadji S, Barbot-Trystram L, et al. Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas. 2011; 40: 359-363
45. Larger E, Philippe MF, Barbot-Trystram L, et al. Pancreatic exocrine function in patients with diabetes. Diabetic Med. 2012; 29: 1047-1054
46. Sarkar SA, Lee CE, Victorino F, et al. Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes. 2012; 61: 436-446
47. Oram RA, McDonald TJ, Shields BM, et al. Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care. 2015; 38: 323-328
48. Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-Autoreactive CD8 T cells in insulitic lesions from recent onset and long-Term type 1 diabetes patients. J Exp Med. 2012; 209: 51-60
49. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of coxsackievirus- And cytokine-induced gene expression in human pancreatic islets. Diabetologia. 2005; 48: 1510-1522
50. Bogdani M, Korpos E, Simeonovic C, et al. Extracellular matrix components in the pathogenesis of type 1 diabetes. Curr Diab Rep. 2014; 14: 1-11
51. Kragl M, Lammert E. Basement membrane in pancreatic islet function. In: Islam MS, editor. The islets of Langerhans. Springer Netherlands: Dordrecht; 2010. pp. 217-234
52. LeBleu VS, MacDonald B, Kalluri R. Structure and function of basement membranes. Exp Biol Med. 2007; 232: 1121-1129
53. Simeonovic CJ, Ziolkowski A, Wu Z, et al. Heparanase and autoimmune diabetes. Frontiers Immunol. 2013; 4: 471
54. Korpos É, Kadri N, Kappelhoff R, et al. The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes. 2013; 62: 531-542
55. Kim A, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Curr Opin Immunol. 2015; 34: 9-15
56. Richardson SJ, Leete P, Dhayal S, et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 2014; 57: 392-401
57. Zanone MM, Favaro E, Ferioli E, et al. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. FASEB J. 2007; 21: 3308-3317
58. Talchai C, Xuan S, Lin HV, et al. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell. 2012; 150: 1223-1234
59. El-Gohary Y, Tulachan S, Wiersch J, et al A smad signaling network regulates islet cell proliferation. Diabetes. 2014; 63: 224-236
60. Antonioli L, Blandizzi C, Csoka B, et al. Adenosine signalling in diabetes mellitus[mdash]pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2015; 11: 228-241
61. Lindskog C, Korsgren O, Ponten F, et al. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. J Proteomics. 2012; 75: 2611-2620
62. Lebastchi J, Herold KC. Immunologic and Metabolic Biomarkers of (-Cell Destruction in the Diagnosis of Type 1 Diabetes. Cold Spring Harb Perspect Med. 2012; 2: a007708